Oric Pharmaceuticals, Inc. · NASDAQ:ORIC

James N. Topper's stake in Oric Pharmaceuticals, Inc. fell to 2.00% (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

James N. Topper's stake in Oric Pharmaceuticals, Inc. fell to 2.00%, 1,410,193 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake: 2.00%
Shares: 1,410,193
Intent: Passive
What changed: Fell below 5%
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	0.90%	605,554
FHMLSP, L.P.	0.90%	605,554
FHMLSP, L.L.C.	0.90%	605,554
Frazier Life Sciences Public Overage Fund, L.P.	0.60%	416,494
FHMLSP Overage, L.P.	0.60%	416,494
FHMLSP Overage, L.L.C.	0.60%	416,494
Frazier Life Sciences X, L.P.	0.20%	129,479
FHMLS X, L.P.	0.20%	129,479
FHMLS X, L.L.C.	0.20%	129,479
Frazier Life Sciences XI, L.P.	0.40%	258,666
FHMLS XI, L.P.	0.40%	258,666
FHMLS XI, L.L.C.	0.40%	258,666
James N. Topper	2.00%	1,410,193
Patrick J. Heron	2.00%	1,410,193
Albert Cha	1.40%	1,022,048
James Brush	1.40%	1,022,048
Daniel Estes	0.40%	258,666

Source

View original at SEC

Related